These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 3030769
1. Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage. Blomhoff HK, Smeland E, Mustafa AS, Godal T, Ohlsson R. Eur J Immunol; 1987 Feb; 17(2):299-301. PubMed ID: 3030769 [Abstract] [Full Text] [Related]
2. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone. Janssen O, Gillis S, Kabelitz D. Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117 [Abstract] [Full Text] [Related]
3. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta. Straub C, Zubler RH. J Immunol; 1989 Jan 01; 142(1):87-93. PubMed ID: 2535862 [Abstract] [Full Text] [Related]
4. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. Kumar A, Rogers T, Maizel A, Sharma S. J Immunol; 1991 Aug 01; 147(3):998-1006. PubMed ID: 1713611 [Abstract] [Full Text] [Related]
5. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells. Konttinen YT, Bluestein HG, Zvaifler NJ. J Immunol; 1985 Apr 01; 134(4):2287-93. PubMed ID: 2857749 [Abstract] [Full Text] [Related]
6. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6. Tosato G, Gerrard TL, Goldman NG, Pike SE. J Immunol; 1988 Jun 15; 140(12):4329-36. PubMed ID: 2836512 [Abstract] [Full Text] [Related]
7. [Epstein-Barr virus associated lymphocyte proliferation]. Stein H, Hummel M, Anagnostopoulos I, Korbjuhn P, Niedobitek G, Dallenbach F, Herbst H. Verh Dtsch Ges Pathol; 1992 Jun 15; 76():79-95. PubMed ID: 1283280 [Abstract] [Full Text] [Related]
8. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation. Fukuda M, Kurosaki H, Sairenji T. J Med Virol; 2006 Nov 15; 78(11):1456-64. PubMed ID: 16998876 [Abstract] [Full Text] [Related]
9. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Chaouchi N, Arvanitakis L, Auffredou MT, Blanchard DA, Vazquez A, Sharma S. Oncogene; 1995 Oct 19; 11(8):1615-22. PubMed ID: 7478586 [Abstract] [Full Text] [Related]
10. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells. Gauchat JF, Gascan H, de Waal Malefyt R, de Vries JE. J Immunol; 1992 Apr 01; 148(7):2291-9. PubMed ID: 1347554 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Yokoi T, Miyawaki T, Yachie A, Kato K, Kasahara Y, Taniguchi N. Immunology; 1990 May 01; 70(1):100-5. PubMed ID: 2162322 [Abstract] [Full Text] [Related]
12. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Stuart AD, Stewart JP, Arrand JR, Mackett M. Oncogene; 1995 Nov 02; 11(9):1711-9. PubMed ID: 7478598 [Abstract] [Full Text] [Related]
13. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB. Nature; 1991 Feb 14; 349(6310):612-4. PubMed ID: 1705663 [Abstract] [Full Text] [Related]
14. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Moss DJ, Misko IS, Burrows SR, Burman K, McCarthy R, Sculley TB. Nature; 1988 Feb 25; 331(6158):719-21. PubMed ID: 2830541 [Abstract] [Full Text] [Related]
15. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes. Tsuchiyama L, Kieran J, Boyle P, Wetzel GD. Hum Antibodies; 1997 Feb 25; 8(1):43-7. PubMed ID: 9265505 [Abstract] [Full Text] [Related]
16. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. Yajima M, Kanda T, Takada K. J Virol; 2005 Apr 25; 79(7):4298-307. PubMed ID: 15767430 [Abstract] [Full Text] [Related]
17. Heterogeneity of EBV-transformable human B lymphocyte populations. Chan MA, Stein LD, Dosch HM, Sigal NH. J Immunol; 1986 Jan 25; 136(1):106-12. PubMed ID: 2999241 [Abstract] [Full Text] [Related]
18. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. J Immunol; 1986 Dec 15; 137(12):3855-60. PubMed ID: 2878044 [Abstract] [Full Text] [Related]
19. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells]. Koizumi S. Hokkaido Igaku Zasshi; 1985 Sep 15; 60(5):724-34. PubMed ID: 3000906 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells. Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A. Immunology; 2006 Mar 15; 117(3):379-85. PubMed ID: 16476057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]